NCT04762888View on ClinicalTrials.gov

68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

June 26, 2025

Study Completion Date

June 26, 2025

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

Computed Tomography

Undergo PET/CT

DRUG

Gallium Ga 68 Gozetotide

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo PET/MRI

PROCEDURE

Positron Emission Tomography

PET/MRI or PET/CT

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Mayo Clinic

OTHER

NCT04762888 - 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer | Biotech Hunter | Biotech Hunter